Dual antiplatelet use in the management of COVID-19 associated acute ischemic stroke reocclusion.
Joshua FelerCarlin C ChuckMatthew AndersonJonathan PoggiJoseph SweeneyKrisztina MoldovanMahesh V JayaramanRyan McTaggartRadmehr TorabiPublished in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2022)
COVID-19 AIS may be associated with a hypercoagulable state which risks malignant reocclusion complicating MT. We found antithrombotic treatment periprocedural cangrelor with or without argatroban transitioned to oral aspirin with ticagrelor to be a viable method for management of these patients.
Keyphrases
- acute ischemic stroke
- coronavirus disease
- sars cov
- end stage renal disease
- percutaneous coronary intervention
- chronic kidney disease
- newly diagnosed
- acute coronary syndrome
- low dose
- peritoneal dialysis
- cardiovascular disease
- coronary artery disease
- respiratory syndrome coronavirus
- risk assessment
- direct oral anticoagulants
- replacement therapy